Carcinoma of the Bladder with Azathioprine Therapy

JAMA: The Journal of the American Medical Association

Volumn 237, Issue 2, 1977, Pages 152-

  Scharf, Jehuda ^a   Nahir, Menachem ^a   Eidelman, Shmuel ^a   Jacobs, Richard ^a   Levin, Dan ^b  

^a Departments of Rheumatology ^*  (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHYLSALAZOSULFAPYRIDINE; PREDNISONE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; BLADDER CANCER; BLADDER CARCINOMA; CARCINOGENESIS; DRUG THERAPY; IMMUNOSUPPRESSIVE TREATMENT; ORAL DRUG ADMINISTRATION; THERAPY; ULCERATIVE COLITIS;

AGED; AZATHIOPRINE; CARCINOMA, TRANSITIONAL CELL; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; URINARY BLADDER NEOPLASMS;

EID: 84941813289     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1977.03270290052028     Document Type: Article

References (3)

1. McAdam L, Paulus AE, Peter BJ: Adenocarcinoma of the lung during azathioprine therapy. Arthritis Rheum 17:92-94, 1974.
2. Wall RL, Clausen KP: Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 293:271-273, 1975.
3. Hakala TR, Lange PH, Castro AE, et al: Antibody induction of lymphocyte-mediated cytotoxicity against human transitional cell carcinomas of the urinary tract. N Engl J Med 291:637-641, 1974.